VC Views - Category - VC Views - BioVox - Life sciences Breakthroughs

Join our mailing list and receive the monthly BioVox newsletter for free!

The million-dollar question: How much do you charge for a lifesaving drug?

Written by Guest Author on Monday 26 August 2019 in the category VC Views with the tags finance, gene therapy, vc views.

The newest generation of ground-breaking gene therapy drugs, Zolgensma and Zynteglo, come with eye-catching price tags of more than a million dollars per treatment. Is the pharma industry reckless…

How do we reduce the high cost of clinical trials?

Written by Guest Author on Thursday 18 July 2019 in the category VC Views with the tags finance, clinical trials, vc views.

Drug development is an exorbitantly expensive endeavor. A large expense factor for developing a new therapy is the high cost of conducting clinical trials. Why are clinical trials so insanely expe…

Betting big on blood screens for early cancer detection

Written by Guest Author on Thursday 27 June 2019 in the category VC Views with the tags finance, cancer, vc views.

The American Society of Clinical Oncology (ASCO) just held their annual gathering in Chicago. The event coincided with some interesting new developments in the field of early cancer detection, as …

OCTIMET Oncology tackling cancer with a new captain at the helm

Written by ALB on Wednesday 29 May 2019 in the category VC Views with the tags cancer, startup, vc views.

In this VC Views article, V-Bio Ventures introduces one of their portfolio companies, OCTIMET. This Belgian oncology startup just added a new member to its executive team, with the appointment of …

Cultured meat, plant-based patties and bug burgers: VCs are backing protein alternatives

Written by Guest Author on Tuesday 16 April 2019 in the category VC Views with the tags finance, food.

When it comes to food, our key sources of nutrition haven’t changed much in the last ten thousand years. Though hyped-up food trends and diets come and go, our ancestors established the status quo…

Closing the gender gap in biotech funding

Written by Guest Author on Tuesday 19 March 2019 in the category VC Views with the tags finance, vision / opinion / people, vc views.

Companies with a good gender balance consistently outperform those with only men in their management teams. Yet despite this, start-ups with female founders and management team members are consist…

Life after a PhD: alternatives to academia

Written by Guest Author on Tuesday 19 February 2019 in the category VC Views with the tags academia, vision / opinion / people, vc views.

Having finished a PhD in life sciences can often leave you wondering: what’s next? The classic question is often “academia or industry?”, with a lot of preconceptions made about both career paths.…

Are we spending too much money on cancer drugs?

Written by Guest Author on Tuesday 22 January 2019 in the category VC Views with the tags cancer, drug discovery, vc views.

November is classically the month where immunotherapy takes center stage, especially at the annual conference of the Society for Immunotherapy of Cancer (SITC, endearingly pronounced sitsie). Imm…

Why start-ups can become mega companies in the pharma sector

Written by ALB on Tuesday 20 November 2018 in the category VC Views with the tags finance, startup, vc views.

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech company. For this to happen, the hurdles that need…

Are tech investments under threat by anti-science sentiments?

Written by ALB on Tuesday 30 October 2018 in the category VC Views with the tags vision / opinion / people, regulatory, vc views.

In biotech, company creation is usually preceded by scientific discoveries presenting solutions to existing problems. Because of this, early stage VC investment is, at its core, a science-driven a…

Flanders.bio GSK V-Bio Ventures UGent Biowin XpandInnovation Itera Life Science Janssen Turnstone KU Leuven

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights.

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.

QUICK LINKS

INSIGHTS ARCHIVE

Read more…

BioVox - Life sciences Breakthroughs

Search

The million-dollar question: How much do you charge for a lifesaving drug?

How do we reduce the high cost of clinical trials?

Betting big on blood screens for early cancer detection

OCTIMET Oncology tackling cancer with a new captain at the helm

Cultured meat, plant-based patties and bug burgers: VCs are backing protein alternatives

Closing the gender gap in biotech funding

Life after a PhD: alternatives to academia

Are we spending too much money on cancer drugs?

Why start-ups can become mega companies in the pharma sector

Are tech investments under threat by anti-science sentiments?

ABOUT BIOVOX - Sharing Life Sciences Innovations

QUICK LINKS

INSIGHTS ARCHIVE

PARTNERS

Sign up to our Mailing List to receive updates of our latest News, Events & Magazines

ABOUT BIOVOX - Sharing Life Sciences Innovations

QUICK LINKS

INSIGHTS ARCHIVE

PARTNERS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines